contact us

targetGroup_clinicianInnovators
targetGroup_ResearchAdministrator
targetGroup_IndustryPartner
targetGroup_Investor

Medication adherence in tuberculosis treatment is critical for patient’s cure, infection control and to minimize development of drug resistance. The current system of Directly Observed Therapy (DOT) involves daily clinic visits by patient for at least 6 months so a healthcare worker can observe the patient take each pill. This is both resource-heavy (both for patient and provider) and seen as inflexible and inconvenient by patients.

The Mobile Interactive Supervised Therapy is an interactive patient-centred system involving smartphone video transmission, notification reminders and streamlined central review. It leverages increasing smartphone penetration, allowing remote implementation of medication adherence with its ease of use.

Project Deliverables

A stable system with i) improved design, usability and ii) integrated features such as cash incentives, face recognition, pill recognition pilot tested with healthy volunteers as well as in select patient groups.


Principal Investigator: Dr James MOLTON

Institution: National University Health System

NHIC Ref: NHIC-I2D-1509082

 

 

See all MEDTECH projects >

NEUROBROWSER™ — AN AUTOMATED EEG INTERPRETATION SYSTEM

Diagnosis and management of neurological disorders relies on visual review of electroencephalogra...

Modular Endoprosthesis for Mandible Reconstruction

Mandible defects may result from trauma, inflammatory diseases or upon tumour resection. The gold...

A Rapid Point-of-Care Test Kit for Diagnosing Zika Virus Infection

The Zika virus (ZIKV) is an emerging infectious agent with severe socio-economic impact due to it...

Assay for Early Detection of Flares in Patients with Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an autoimmune condition which affects multiple organ system...

Novel inhibitors for Natural Killer/T-cell lymphoma (NKTCL)

The Natural Killer/T-cell lymphoma (NKTCL) is a subtype of Non-Hodgkin’s lymphoma (NHL) which is...

Towards a Novel Drug Therapy for Treatment-Resistant Depression: Adjunct 5-HTP Slow-Release

Depression is the leading cause of disability worldwide, and is a major contributor to the global...

OUR PARTNERS

Clinical Partners


nhg logonuhs logosinghealth

 

Academic Partners


lkc medicalnus faculty of dentistrynus sphnus somduke nus

 

Supporting Partners


bms ipodxdipinmrcSCRIseriSMARTEnterpriseSG